Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: A study of 36 cases

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 135, Issue 1, 2007, Pages 53-57

  Berrebi, Alain ^a   Bardou, Magali ^a   Bessieres, Marie Hélène ^b   Nowakowska, Dorota ^c   Castagno, Romina ^a   Rolland, Michel ^d   Wallon, Martine ^e   Franck, Jacqueline ^f   Bongain, André ^g   Monnier Barbarino, Patricia ^h   Assouline, Corinne ^d   Cassaing, Sophie ^b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b CHU RANGUEIL   (France)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^d HÔPITAL DES ENFANTS   (France)

^e CROIX ROUSSE HOSPITAL   (France)

^f TIMONE HOSPITAL   (France)

^g CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^h Maternite Regionale Universitaire   (France)

Author keywords

Pregnancy; Pregnancy termination; Pyrimethamine sulfonamides; Ultrasound screening

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY DETECTION; ARTICLE; CHORIORETINITIS; CLINICAL ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DISEASE SEVERITY; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; FRANCE; HUMAN; INTELLIGENCE; MENTAL DEVELOPMENT; OUTCOME ASSESSMENT; PREGNANCY TERMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TOXOPLASMA GONDII; VISUAL IMPAIRMENT;

EID: 35649003874     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.11.002     Document Type: Article

References (16)

1. Baril L., Ancelle T., Thulliez P., et al. Facteurs de risque d'acquisition de la toxoplasmose chez les femmes enceintes en 1995 (France). BEH 16 (1996) 73-75
2. Berrebi A., Kobuch W.E., Bessieres M.H., et al. Termination of pregnancy for maternal toxoplasmosis. Lancet 344 (1994) 36-39
3. Dunn D., Wallon M., Peyron F., Petersen E., Peckham C., and Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353 (1999) 1829-1833
4. Therby D., Cosson M., Dubecq-Princeteau F., et al. Intérêts et limites des investigations complémentaires en cas de séroconversion toxoplasmique en cours de grossesse: à propos d'un cas et revue de la literature. J Gynecol Obstet Biol Reprod (Paris) 25 (1996) 505-509
5. Roth P., Maillet R., Dalphin M.L., Schaal J.P., and Colette C. Toxoplasmose et grossesse: une simplification des procédures est-elle possible?. J Gynecol Obstet Biol Reprod (Paris) 22 (1993) 29-32
6. Pratlong F., Boulot P., Villena I., et al. Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. Br J Obstet Gynaecol 103 (1996) 552-557
7. Foulon W., Villena I., Stray-Pedersen B., et al. Treatment of toxoplasmosis during pregnancy: impact on fetal transmission and children's sequelae at one year of age, a multicenter study. Am J Obstet Gynecol 180 (1999) 410-415
8. Jenum P.A., Stray-Pedersen B., Melby K.K., et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 36 (1988) 2900-2906
9. Wallon M., Gaucherand P., Al Kurdi M., and Peyron F. Infection toxoplasmique de début de grossesse: conséquences et conduite à tenir. J Gynecol Obstet Biol Reprod (Paris) 31 (2002) 478-484
10. Gilbert M., Gras L., and and European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 110 (2003) 112-120
11. Bessieres M.H., Berrebi A., Rolland M., et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on results of neonatal tests. Eur J Obstet Gynecol Reprod Biol 94 (2001) 37-45
12. Couvreur J., Thulliez P., Daffos F., et al. Foetopathie toxoplasmique: traitement in utero par l'association pyriméthanine-sulfonamides. Arch Fr Pediatr 48 (1991) 397-403
13. Gras L., Gilbert R.E., Ades A.E., and Dunn D.T. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 30 (2001) 1309-1313
14. Wallon M., Kodjikian L., Binquet C., et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113 (2004) 1567-1572
15. Daffos F., Forestier F., Capella-Pavlovsky M., et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318 (1988) 271-275
16. Hohlfeld P., Daffos F., Thulliez P., et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115 (1989) 765-769